Judith M. Matthews
2022
In 2022, Judith M. Matthews earned a total compensation of $778.8K as Chief Financial Officer at Iterum Therapeutics plc, a 82% decrease compared to previous year.
Compensation breakdown
| Bonus | $238,000 |
|---|---|
| Non-Equity Incentive Plan | $142,800 |
| Salary | $395,395 |
| Other | $2,622 |
| Total | $778,817 |
Matthews received $395.4K in salary, accounting for 51% of the total pay in 2022.
Matthews also received $238K in bonus, $142.8K in non-equity incentive plan and $2.6K in other compensation.
Rankings
In 2022, Judith M. Matthews' compensation ranked 3,549th out of 5,736 executives tracked by ExecPay. In other words, Matthews earned more than 38.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,549 out of 5,736 | 38th |
Division Manufacturing | 2,019 out of 3,125 | 35th |
Major group Chemicals And Allied Products | 966 out of 1,416 | 32nd |
Industry group Drugs | 904 out of 1,317 | 31st |
Industry Pharmaceutical Preparations | 659 out of 963 | 32nd |
Source: SEC filing on March 16, 2023.
Matthews' colleagues
We found two more compensation records of executives who worked with Judith M. Matthews at Iterum Therapeutics plc in 2022.